Trifluoromethanesulfonic Acid

Trifluoromethanesulfonic Acid

SCHEMBL2844529

COC(=O)c1c2ccccc2[n+](Cc2ccccc2)c2ccccc12.O=S(=O)([O-])C(F)(F)F

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.38
APOBEC3A P31941 1/20 0.38
APOBEC3G Q9HC16 1/20 0.38
ALDH1A1 P00352 5/20 0.35
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
NPSR1 Q6W5P4 2/20 0.35
ACHE P22303 1/20 0.35
LMNA P02545 2/20 0.34
PLA2G2A P14555 1/20 0.34
CA12 O43570 1/20 0.34
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
CA7 P43166 1/20 0.34
CA9 Q16790 1/20 0.34
CA14 Q9ULX7 1/20 0.34
MAPT P10636 3/20 0.34
GAA P10253 2/20 0.34
PKM P14618 2/20 0.34
POLB P06746 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13789603 0.88 ALOX5 (0.46) ALOX5APOBEC3AAPOBEC3GALDH1A1MEN1
Trifluoromethanesulfonic Acid SCHEMBL2996949 0.83 ACHE (0.42) ACHELMNACA12CA1CA2
Trifluoromethanesulfonic Acid SCHEMBL2992230 0.80 ACHE (0.37) ALDH1A1MEN1KMT2AACHELMNA
Trifluoromethanesulfonic Acid SCHEMBL5672061 0.73 NPSR1 (0.52) ALDH1A1NPSR1ACHELMNACA1
Trifluoromethanesulfonic Acid SCHEMBL7044721 0.73 KMT2A (0.38) ALDH1A1MEN1KMT2ANPSR1LMNA
Trifluoromethanesulfonic Acid SCHEMBL7047547 0.73 MEN1 (0.35) MEN1KMT2AACHEMAPTGAA
Trifluoromethanesulfonic Acid SCHEMBL5705540 0.72 MAPT (0.39) NPSR1ACHEMAPT
Trifluoromethanesulfonic Acid SCHEMBL38665301 0.72 MAPT (0.39) NPSR1ACHEMAPT
Trifluoromethanesulfonic Acid SCHEMBL7043963 0.72 CA1 (0.40) ALDH1A1KMT2ALMNACA1CA2
Trifluoromethanesulfonic Acid SCHEMBL7051082 0.71 KMT2A (0.45) ALDH1A1MEN1KMT2ALMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2139850-B1 INHIBITORS OF HISTONE DEACETYLASE METHYLGENE INC (CA) 2018-09-12 EP disclosed
US-9096565-B2 Inhibitors of histone deacetylase METHYLGENE INC. (CA) 2015-08-04 US disclosed
EP-2139850-A1 INHIBITORS OF HISTONE DEACETYLASE Methylgene, Inc. (CA) 2010-01-06 EP disclosed
US-20090181943-A1 Inhibitors of Histone Deacetylase METHYLGENE INC. (CA) 2009-07-16 US disclosed
WO-2008122115-A1 INHIBITORS OF HISTONE DEACETYLASE METHYLGENE INC. (CA) 2008-10-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090181943-A1 Inhibitors of Histone Deacetylase HDAC1, HDAC11, HDAC3 ALOX5 2866/4885APOBEC3A 3765/4885APOBEC3G 3561/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.